tradingkey.logo

BRIEF-Fresenius Kabi Otulfi Will Be Available In U.S. Some Presentations

ReutersMar 3, 2025 2:43 PM

- Fresenius Medical Care AG FMEG.DE:

  • FRESENIUS KABI: OTULFI WILL BE AVAILABLE IN U.S. SOME PRESENTATIONS

  • FRESENIUS KABI: OTULFI IN 45 MG/0.5 ML SINGLE-DOSE VIAL FOR SUBCUTANEOUS INJECTION IS EXPECTED TO RECEIVE FDA APPROVAL IN H1 2025

Source text: ID:nBw2yxSBza

Further company coverage: FMEG.DE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI